PRE logo

Prenetics Global Limited (PRE)

Profile

Full Name

Prenetics Global Limited

Ticker Symbol

PRE

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

Hong Kong

IPO

July 16, 2021

Indexes

Not included

Website

http://www.prenetics.com

Employees

320

Key Details

Price

$5.32(+1.63%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$30.62M(+40.83% YoY)

Annual EPS

-$3.71(+33.51% YoY)

PE ratio

-

Next earnings date

Jun 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.32
PRE price is $5.32

30-Day Relative Volume

0.61
PRE 30-day relative volume is 0.61

Price Performance

Price Most recent change

+1.63%
PRE price was up +1.63% on May 2, 2025

Price YTD change

-8.36%
PRE price is down -8.36% since January 1st

Price 1-year change

-0.28%
PRE price is down -0.28% year-on-year

Price 3-year change

-95.42%
PRE price is down -95.42% over the past 3 years

Price Range

Price All-time high

$131.25
PRE price is currently -95.95% below its historical high of $131.25

Price 3-year low

$2.85
PRE price is currently +86.49% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$64.93M
PRE market capitalization is $64.93 million

Market cap 3-year change

-
PRE market capitalization 3-year change is unknown

Market cap All-time high

$848.99M
PRE market capitalization is currently -92.35% below its historical high of $848.99 million

Market cap sector rank

39.01%
PRE market capitalization is higher than 39.01% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
PRE {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-
PRE shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.27
PRE beta is -0.27

200-day SMA

$4.90
PRE price is currently +8.44% above its 200-day simple moving average

50-day SMA

$4.42
PRE price is currently +20.31% above its 50-day simple moving average

RSI

73.34
PRE 14-day relative strength index is 73.34

Volume

0.61
PRE 30-day relative volume is 0.61

ATR

$0.37
PRE average true range is $0.37

10-day Historical Volatility

64.88%
PRE 10-day historical volatility is 64.88%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$30.62M
PRE annual revenue is $30.62 million

Revenue Analysts estimate

$79.10M
PRE annual revenue is currently -61.29% lower than the consensus analysts' forecast

Revenue 1-year change

+40.83%
PRE annual revenue is up +40.83% year-on-year

Revenue Sector rank

39.3%
PRE annual revenue is higher than 39.3% of companies in Healthcare sector

EPS

EPS

-$3.71
PRE annual earnings per share is -$3.71

EPS Analysts estimate

-
PRE annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+33.51%
PRE annual earnings per share is up +33.51% year-on-year

EPS Sector rank

24.01%
PRE annual earnings per share is higher than 24.01% of companies in Healthcare sector

Profit

Gross profit

$15.40M
PRE annual gross profit is $15.40 million

Gross margin

50.29%
PRE annual gross profit margin is 50.29%

Operating profit

-$50.89M
PRE annual operating income is -$50.89 million

Operating margin

-166.19%
PRE annual operating profit margin is -166.19%

Net income

-$46.30M
PRE annual net profit is -$46.30 million

Net margin

-151.22%
PRE annual net profit margin is -151.22%

Expenses

Total expenses

$81.51M
PRE annual total expenses is $81.51 million

Operating expenses

$66.29M
PRE annual total operating expenses is $66.29 million

Cost of goods sold

$15.22M
PRE annual cost of goods sold is $15.22 million

Selling, general & administrative expenses

$55.37M
PRE annual SGA is $55.37 million

Depreciation and amortization

$5.93M
PRE annual depreciation & amortization is $5.93 million

Interest expense

$203.00K
PRE annual interest expense is $203.00 thousand

Income tax

-$7.87M
PRE annual income tax is -$7.87 million

EBIT & EBITDA

EBIT

-$57.50M
PRE annual earnings before interest & taxes is -$57.50 million

EBITDA

-$51.57M
PRE annual EBITDA is -$51.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$213.57M
PRE annual total assets is $213.57 million

Non current assets

$127.43M
PRE annual long term assets is $127.43 million

Current assets

$86.15M
PRE annual total current assets is $86.15 million

Cash and cash equivalents

$52.25M
PRE annual cash & cash equivalents is $52.25 million

Accounts receivable

$5.24M
PRE annual accounts receivable is $5.24 million

Inventory

$6.57M
PRE annual inventory is $6.57 million

Liabilities

Total liabilities

$42.23M
PRE annual total liabilities is $42.23 million

Long term liabilities

$5.68M
PRE annual total long term liabilities is $5.68 million

Current liabilities

$36.55M
PRE annual total current liabilities is $36.55 million

Accounts payable

$3.67M
PRE annual accounts payable is $3.67 million

Debt

Total debt

$5.77M
PRE annual total debt is $5.77 million

Total debt 1-year change

+143.65%
PRE annual total debt is up +143.65% year-on-year

Long term debt

$3.01M
PRE annual long term debt is $3.01 million

Short term debt

$2.76M
PRE annual short term debt is $2.76 million

Equity & Capital

Shareholders equity

$170.39M
PRE annual stockholders equity is $170.39 million

Book value

$170.39M
PRE annual book value is $170.39 million

Retained earnings

-$517.07M
PRE annual retained earnings is -$517.07 million

Working capital

$49.60M
PRE annual working capital is $49.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$28.87M
PRE annual cash flow from operations is -$28.87 million

Cash from operations 1-year change

-109.76%
PRE annual cash flow from operations is down -109.76% year-on-year

Cash from investing

$38.54M
PRE annual cash flow from investing activities is $38.54 million

Cash from investing 1-year change

+146.46%
PRE annual cash flow from investing activities is up +146.46% year-on-year

Cash from financing

-$3.34M
PRE annual cash flow from financing activities is -$3.34 million

Cash from financing 1-year change

+28.93%
PRE annual cash flow from financing activities is up +28.93% year-on-year

CAPEX

CAPEX

$1.06M
PRE annual capital expenditures is $1.06 million

CAPEX 1-year change

+16.78%
PRE annual capital expenditures is up +16.78% year-on-year

Free Cash Flow

Free cash flow

-$29.94M
PRE annual free cash flow is -$29.94 million

Free cash flow 1-year change

-103.99%
PRE annual free cash flow is down -103.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

50.29%
PRE annual gross profit margin is 50.29%

Operating margin

-166.19%
PRE annual operating profit margin is -166.19%

Net margin

-151.22%
PRE annual net profit margin is -151.22%

ROA & ROE

ROA

-19.80%
PRE annual return on assets is -19.80%

ROE

-24.27%
PRE annual return on equity is -24.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRE price to earnings ratio value is unknown

PE ratio Sector rank

-
PRE price to earnings ratio is unknown

PB Ratio

PB ratio

0.38
PRE price to book ratio is 0.38

PB ratio Sector rank

24.78%
PRE price to book ratio is higher than 24.78% of companies in Healthcare sector

PS Ratio

PS ratio

2.12
PRE price to sales ratio is 2.12

PS ratio Sector rank

42.1%
PRE price to sales ratio is higher than 42.1% of companies in Healthcare sector

Enterprise value

Enterprise value

-
PRE enterprise value value is unknown

Enterprise value Sector rank

-
PRE enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
PRE EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
PRE EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.36
PRE annual current ratio is 2.36

Quick ratio

2.18
PRE annual quick ratio is 2.18

Leverage

Debt to equity

0.00
PRE annual debt to equity ratio is 0.00

Interest coverage ratio

-283.25
PRE annual interest coverage ratio is -283.25

Risk & Stability

Piotroski F-Score

-
PRE piotroski f-score value is unknown

Altman Z-Score

-2.93
PRE altman z-score is -2.93

Analyst ratings

Recent major analysts updates

Jan 16, 25 Cantor Fitzgerald
Overweight
Dec 4, 24 Cantor Fitzgerald
Overweight
Apr 4, 24 Cantor Fitzgerald
Overweight
Sep 26, 23 Cantor Fitzgerald
Overweight
Sep 19, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight
Jan 18, 23 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

APLT logo
Applied Therapeutics (APLT)
FORA logo
Forian (FORA)
XTNT logo
Xtant Medical Holdings (XTNT)
ABOS logo
Acumen Pharmaceuticals (ABOS)
CTMX logo
CytomX Therapeutics (CTMX)
ANRO logo
Alto Neuroscience (ANRO)
OWLT logo
Owlet (OWLT)
Citius Oncology (CTOR)
CPIX logo
Cumberland Pharmaceuticals (CPIX)
  • What is the ticker symbol for Prenetics Global Limited?
  • Does Prenetics Global Limited pay dividends?
  • What sector is Prenetics Global Limited in?
  • What industry is Prenetics Global Limited in?
  • What country is Prenetics Global Limited based in?
  • When did Prenetics Global Limited go public?
  • Is Prenetics Global Limited in the S&P 500?
  • Is Prenetics Global Limited in the NASDAQ 100?
  • Is Prenetics Global Limited in the Dow Jones?
  • When was Prenetics Global Limited's last earnings report?
  • When does Prenetics Global Limited report earnings?
  • Should I buy Prenetics Global Limited stock now?

What is the ticker symbol for Prenetics Global Limited?

The ticker symbol for Prenetics Global Limited is NASDAQ:PRE

Does Prenetics Global Limited pay dividends?

No, Prenetics Global Limited does not pay dividends

What sector is Prenetics Global Limited in?

Prenetics Global Limited is in the Healthcare sector

What industry is Prenetics Global Limited in?

Prenetics Global Limited is in the Diagnostics & Research industry

What country is Prenetics Global Limited based in?

Prenetics Global Limited is headquartered in Hong Kong

When did Prenetics Global Limited go public?

Prenetics Global Limited's initial public offering (IPO) was on July 16, 2021

Is Prenetics Global Limited in the S&P 500?

No, Prenetics Global Limited is not included in the S&P 500 index

Is Prenetics Global Limited in the NASDAQ 100?

No, Prenetics Global Limited is not included in the NASDAQ 100 index

Is Prenetics Global Limited in the Dow Jones?

No, Prenetics Global Limited is not included in the Dow Jones index

When was Prenetics Global Limited's last earnings report?

Prenetics Global Limited's most recent earnings report was on Mar 5, 2025

When does Prenetics Global Limited report earnings?

The next expected earnings date for Prenetics Global Limited is Jun 18, 2025

Should I buy Prenetics Global Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page